Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-06-01 @ 6:44 AM
Study NCT ID:
NCT01938560
Status:
COMPLETED
Last Update Posted:
2014-10-01
First Post:
2013-09-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
REMS Retigabine Study
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
116490
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None